FDA panel rejects testosterone patch for women on safety grounds.
Moynihan
Ray
R
D000279:Administration, Cutaneous; D017277:Drug Approval; D005260:Female; D006801:Humans; D007989:Libido; D013739:Testosterone / Q000008:administration & dosage*; D014481:United States; D014486:United States Food and Drug Administration
D013739:Testosterone